Xcout Intel
Syantra Diagnostics
Syantra Diagnostics, based in Calgary, Canada, is developing a blood-based diagnostic test for breast cancer. This revolutionary test aims to be rapid, economical, and accurate, regardless of various factors, to improve breast cancer detection.
Subscribe to see Syantra Diagnostics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Syantra Diagnostics at a glance
Syantra Diagnostics is a biotech company headquartered in Canada. Xcout tracks 14 named people at Syantra Diagnostics, including Rob Lozuk (Chief Executive Officer).
Syantra Diagnostics leadership
- Rob LozukChief Executive Officer
- Francine StirlingChief of Staff
- Bob ShepherdCo-Founder & Chief Operating Officer
- Kristina Rinker, PhD, PEngCo-Founder & Chief Scientific Officer
- Kenneth Fuh, PhD, MLTCo-Founder & Director, Product Development
- Randy Moore, MD FRCSC FACSCo-Founder & Medical Director
8 more named people on record for Syantra Diagnostics, with roles, board committees and tenure — see the full roster →
Syantra Diagnostics competitors
A few of Syantra Diagnostics's closest competitors — see the full list of competitors and alternatives →
Signatur Biosciences develops a molecular diagnostic platform that utilizes standard qPCR equipment to analyze complex RNA signatures and perform precision testing for diseases such as breast cancer. The company's kits are designed to decentralize diagnostics by replacing complex, expensive laboratory workflows with simplified assays compatible with existing hospital infrastructure.
Biodesix, Inc. is a public diagnostic solutions company founded in 2006 and headquartered in Louisville, Colorado. The company specializes in diagnostic testing and development services focused on discovering blood-based tests for cancer management.
SAGA Diagnostics provides ultra-sensitive, blood-based molecular residual disease (MRD) detection and monitoring tests for cancer patients. The company's flagship platform, Pathlight, uses tumor whole-genome sequencing and personalized digital PCR assays to detect circulating tumor DNA, primarily serving clinicians and biopharmaceutical partners for early cancer detection and treatment tracking.
PinkDx, Inc., also known as The Gyne Cancer Company, is headquartered in San Francisco, California. The company specializes in advanced gynecologic cancer diagnostics and developing innovative patient testing solutions.
MDNA Life Sciences, Inc. develops non-invasive, blood-based diagnostic tests utilizing patented mitochondrial DNA technology to detect diseases such as cancer at early stages. The company serves patients and healthcare providers by offering accurate screening solutions designed to improve disease detection and reduce the need for unnecessary invasive surgeries.
Capio Biosciences is an oncology diagnostics company that develops advanced technologies for capturing and analyzing circulating tumor cells (CTCs) from whole blood. Its proprietary CapioCyte platform offers enhanced sensitivity compared to traditional methods, serving as a research tool designed to help oncologists make informed cancer treatment decisions.
Get Syantra Diagnostics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Syantra Diagnostics in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access